417 related articles for article (PubMed ID: 37108251)
1. Pharmaco-Omics in Psoriasis: Paving the Way towards Personalized Medicine.
Antonatos C; Asmenoudi P; Panoutsopoulou M; Vasilopoulos Y
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108251
[TBL] [Abstract][Full Text] [Related]
2. Not your average joint: Towards precision medicine in psoriatic arthritis.
Castillo R; Scher JU
Clin Immunol; 2020 Aug; 217():108470. PubMed ID: 32473975
[TBL] [Abstract][Full Text] [Related]
3. Omics sciences and precision medicine in glioblastoma.
Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma.
Alaaeddine R; Fayad M; Nehme E; Bahmad HF; Kobeissy F
Adv Exp Med Biol; 2017; 1007():59-70. PubMed ID: 28840552
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional Basis of Psoriasis from Large Scale Gene Expression Studies: The Importance of Moving towards a Precision Medicine Approach.
Krishnan VS; Kõks S
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682804
[TBL] [Abstract][Full Text] [Related]
6. Rapid identification and validation of novel targeted approaches for Glioblastoma: A combined ex vivo-in vivo pharmaco-omic model.
Daher A; de Groot J
Exp Neurol; 2018 Jan; 299(Pt B):281-288. PubMed ID: 28923369
[TBL] [Abstract][Full Text] [Related]
7. Multi-Omics Research Strategies for Psoriasis and Atopic Dermatitis.
Guo Y; Luo L; Zhu J; Li C
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175722
[TBL] [Abstract][Full Text] [Related]
8. Differences between psoriatic arthritis and psoriasis in multi-omics.
Gao S; Song H
Arch Dermatol Res; 2024 May; 316(6):217. PubMed ID: 38787526
[TBL] [Abstract][Full Text] [Related]
9. Unveiling the future of metabolic medicine: omics technologies driving personalized solutions for precision treatment of metabolic disorders.
Singh S; Sarma DK; Verma V; Nagpal R; Kumar M
Biochem Biophys Res Commun; 2023 Nov; 682():1-20. PubMed ID: 37788525
[TBL] [Abstract][Full Text] [Related]
10. Omics sciences and precision medicine in lung cancer.
Micheletti C; Dhuli K; Donato K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):37-45. PubMed ID: 37994747
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Treatment-Relevant Immune Biomarkers in Psoriasis and Atopic Dermatitis: Toward Personalized Medicine in Dermatology.
Mortlock RD; Ma EC; Cohen JM; Damsky W
J Invest Dermatol; 2023 Aug; 143(8):1412-1422. PubMed ID: 37341663
[TBL] [Abstract][Full Text] [Related]
12. Patient-specific multi-omics models and the application in personalized combination therapy.
John A; Qin B; Kalari KR; Wang L; Yu J
Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
[TBL] [Abstract][Full Text] [Related]
13. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine.
Turanli B; Karagoz K; Gulfidan G; Sinha R; Mardinoglu A; Arga KY
Curr Pharm Des; 2018; 24(32):3778-3790. PubMed ID: 30398107
[TBL] [Abstract][Full Text] [Related]
14. Omics sciences and precision medicine in thyroid cancer.
Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
[TBL] [Abstract][Full Text] [Related]
15. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
Ahmed Z
Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
[TBL] [Abstract][Full Text] [Related]
16. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
17. ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases.
Vetrano S; Bouma G; Benschop RJ; Birngruber T; Costanzo A; D'Haens GRAM; Frasca L; Hillenbrand R; Iversen L; Johansen C; Kaser A; Koenen HJPM; Noehammer C; Peyrin-Biroulet L; Raes J; Ricotti L; Rosenstiel P; Satagopam VP; Schreiber S; Vermeire S; Wollenberg A; Weidinger S; Ziemek D; Danese S;
Front Immunol; 2022; 13():1002629. PubMed ID: 36439150
[TBL] [Abstract][Full Text] [Related]
18. The use of biomarkers as a tool for novel psoriatic disease drug discovery.
Aggarwal D; Arumalla N; Jethwa H; Abraham S
Expert Opin Drug Discov; 2018 Sep; 13(9):875-887. PubMed ID: 30124339
[TBL] [Abstract][Full Text] [Related]
19. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
Banerjee S; Prabhu Basrur N; Rai PS
Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
Ahmed Z
Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
